Sanofi Paid $14.6bn In Rebates In 2020; Net Prices Were Down
US Average Aggregate Net Prices Declined 7.8%
The company released an annual pricing report, showing that Sanofi's US average net prices declined for the fifth year in a row.
You may also be interested in...
Vaccine spending projections represent about 2% of total spending on medicines IQVIA said. Increased spending will be partly offset by COIVD-19 disruptions, however.
Janssen's net drug prices declined for the fourth year in a row in 2020, while list prices increased 3.8%, according to the company's drug pricing report.
The rise of the biosimilars has been predicted for many years, but the commercial dynamics after complex biologic drugs’ loss of exclusivity suggests that it may not be so straightforward.